about
Drug-Induced Liver Toxicity and Prevention by Herbal Antioxidants: An OverviewEngineered silybin nanoparticles educe efficient control in experimental diabetesPolyamidoamine dendrimers as potential drug carriers for enhanced aqueous solubility and oral bioavailability of silybin.Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.Silymarin Inhibits Cytokine-Stimulated Pancreatic Beta Cells by Blocking the ERK1/2 Pathway.Herbal modulation of P-glycoprotein.A novel approach for the efficient extraction of silybin from milk thistle fruitsA survey of Chinese herbal ingredients with liver protection activitiesSilybin and the liver: from basic research to clinical practice.In-vitro and In-vivo Evaluation of Silymarin Nanoliposomes against Isolated Methicillin-resistant Staphylococcus aureusSilymarin Inhibits Morphological Changes in LPS-Stimulated Macrophages by Blocking NF-κB Pathway.HiFSA fingerprinting applied to isomers with near-identical NMR spectra: the silybin/isosilybin caseSilymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.Silymarin Ameliorates Metabolic Dysfunction Associated with Diet-Induced Obesity via Activation of Farnesyl X Receptor.Mixed micelles loaded with silybin-polyene phosphatidylcholine complex improve drug solubilityHerb-drug interactions: focus on metabolic enzymes and transporters.Silymarin Constituents Enhance ABCA1 Expression in THP-1 Macrophages.Impact of Dendrimers on Solubility of Hydrophobic Drug MoleculesDissolution thermodynamics and solubility of silymarin in PEG 400-water mixtures at different temperatures.A new pro-prodrug aminoacid-based for trans-ferulic Acid and silybin intestinal release.Silymarin effect on amyloid-β plaque accumulation and gene expression of APP in an Alzheimer's disease rat model.Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo.Preparation, characterization and evaluation of Marsupsin-phospholipid complex.Targeting silymarin for improved hepatoprotective activity through chitosan nanoparticles.Free radical scavenging reactions and antioxidant activities of silybin: mechanistic aspects and pulse radiolytic studies.Solid-state fermentation of industrial solid wastes from the fruits of milk thistle Silybum marianum for feed quality improvement.Comparison of acid degumming and enzymatic degumming process for Silybum marianum seed oil.Effect of continuous silymarin administration on oral talinolol pharmacokinetics in healthy volunteers.Selected hepatoprotective herbal medicines: Evidence from ethnomedicinal applications, animal models, and possible mechanism of actions.Influence of Flavonoids on Mechanism of Modulation of Insulin Secretion.Silymarin mitigates lung impairments in a rat model of acute respiratory distress syndrome.Effects of milk thistle meal on performance, ileal bacterial enumeration, jejunal morphology and blood lipid peroxidation in laying hens fed diets with different levels of metabolizable energy.Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration.Antimutagenic, Antigenotoxic, and Anticytotoxic Activities of Silybum Marianum [L.] Gaertn Assessed by the Salmonella Mutagenicity Assay (Ames Test) and the Micronucleus Test in Mice Bone Marrow.Electrochemical Determination of Capsaicin and Silymarin Using a Glassy Carbon Electrode Modified by Gold Nanoparticle Decorated Multiwalled Carbon NanotubesBaicalein Enhances the Oral Bioavailability and Hepatoprotective Effects of Silybin Through the Inhibition of Efflux Transporters BCRP and MRP2Characterization andIn VitroSustained Release of Silibinin from pH Responsive Carbon Nanotube-Based Drug Delivery System
P2860
Q26767516-6018D322-B5B7-415F-8590-2066D3EA7A32Q28540351-8310482A-9961-4DE9-ABC0-D3C9F87A4963Q33717351-B74D7C90-282E-411A-8FCD-0666E3F14A34Q34030782-11E26A5B-29C6-4A60-A9AC-4ECB5D9FB9C1Q34039802-E1DD3719-647B-45DD-8CC6-D20E0CE7D6FBQ34312035-CBD88C51-C8FD-464C-9D81-4633655E8341Q34553288-332FCD11-6A6B-43A8-9E61-E2EF3B57C3CAQ34626804-09919240-68D5-42BC-A4A8-05FECA7FE712Q34629765-6A978120-B308-45E2-933F-469F09FB57F2Q35484155-6D008404-6FF4-4AD1-B749-C33BF55BA5A6Q35578598-817C2AC9-377E-4EDA-A5BC-F03983A36FAAQ36807240-06E1FD6D-1ABF-44BD-8277-C2C8F60CD2CDQ37164213-308C5AC4-EB62-42E9-8A80-0BCF0957A4D7Q37290054-649A59DD-E6A5-4E1B-82AF-B69CE78CBB13Q37729847-5D29AB99-B40D-47E5-87D2-84960AF00A53Q37964576-E15B7259-52D4-4048-9BC0-3332788996B9Q38336287-C04BF238-F953-4B9F-B7FD-1839C324E1BAQ39339379-FBC90E1A-A2AE-47C2-9BB6-D1A94300E972Q41386931-7CC55B6C-EB32-4C43-BE41-420743241E86Q41815664-67F54CBA-E385-48A7-B992-CD6F887BDADAQ41895176-E7043A5D-6EB5-4915-AB5A-6D7FE6D380E2Q42091649-965DDEF7-C81D-41F6-94FE-2E2169CED85AQ42374398-AA1B4288-10F9-456B-A59E-817B192EA671Q43025525-17604835-0B6D-4CFF-B9FC-B1AAA074A97EQ43290979-6C5A760C-E3BE-46C0-B299-BDF17E0D4309Q43359414-D86BD959-DCEA-440A-94C4-923B4168E2E0Q45716069-A23F5065-8356-4619-A3DB-FFF749EFA1F2Q45953187-513A4C76-86D8-4C4D-9110-D9AC5CA8DC96Q46280777-74A90E91-AEC1-4894-9C48-94F25A29333BQ47117610-15DC58F2-05ED-4915-972B-EEF3131B06ADQ47446479-06D29D27-A068-447A-9077-83220DE6F902Q48059750-148289A6-3A5D-44C1-B104-A0E161FE543AQ48070717-A03F6820-F46B-4F76-8E37-0984C54B4BE4Q49964004-D434817D-87F0-43C8-8416-FDEA1FB3E73BQ58128419-F0F67421-D096-479D-AAE1-EBE7773C0ACBQ58707702-C83CA2F9-00BA-4E47-A708-C858CF2402C4Q59060263-6702A23E-5AEC-4905-AD2F-C1C29DB70FB0
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մարտին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Analysis of the active components of silymarin.
@ast
Analysis of the active components of silymarin.
@en
Analysis of the active components of silymarin.
@nl
type
label
Analysis of the active components of silymarin.
@ast
Analysis of the active components of silymarin.
@en
Analysis of the active components of silymarin.
@nl
prefLabel
Analysis of the active components of silymarin.
@ast
Analysis of the active components of silymarin.
@en
Analysis of the active components of silymarin.
@nl
P2093
P1476
Analysis of the active components of silymarin.
@en
P2093
P304
P356
10.1016/S0021-9673(02)01971-4
P407
P577
2003-03-01T00:00:00Z